Description
Ibrutinib: a major breakthrough in the treatment of chronic lymphocytic leukaemia (CLL) and other lymphoproliferative disorders
€2.42
Ibrutinib: a major breakthrough in the treatment of chronic lymphocytic leukaemia (CLL) and other lymphoproliferative disorders
Reviews
There are no reviews yet.